公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | Clinical recommendations for defining platinum unsuitable head and neck cancer patient populations on chemoradiotherapy: A literature review | Ahn M.-J.; D'Cruz A.; Vermorken J.B.; JO-PAI CHEN ; Chitapanarux I.; Dang H.Q.T.; Guminski A.; Kannarunimit D.; Lin T.-Y.; Ng W.T.; Park K.-U.; Chan A.T.C. | Oral Oncology | 71 | 70 | |
2021 | A phase ib study of alpelisib or buparlisib combined with tamoxifen plus goserelin in premenopausal women with HR-positive HER2-negative advanced breast cancer | YEN-SHEN LU ; Lee K.S.; Chao T.-Y.; Tseng L.-M.; Chitapanarux I.; Chen S.-C.; Liu C.-T.; Sohn J.; Kim J.H.; Chang Y.-C.; Yang Y.; Shotelersuk K.; Jung K.H.; Valenti R.; Slader C.; Gao M.; Park Y.H. | Clinical Cancer Research | 23 | 16 | |
2010 | Phase II study of capecitabine (Ro 09-1978) in patients who have failed first line treatment for locally advanced and/or metastatic cervical cancer | Lorvidhaya V.; Chitapanarux I.; Phromratanapongse P.; Kamnerdsupaphon P.; Tharavichitkul E.; Lertsanguansinchai P.; CHANG-YAO HSIEH ; Sukthomya V. | Japanese Journal of Cancer and Chemotherapy | 6 | 0 |